Literature DB >> 19557311

Interdisciplinary review for correlation between the plant origin capsaicinoids, non-steroidal antiinflammatory drugs, gastrointestinal mucosal damage and prevention in animals and human beings.

Gyula Mózsik1, Tibor Past, Omar M E Abdel Salam, Mónika Kuzma, Pál Perjési.   

Abstract

BACKGROUND: The plant origin capsaicinoids (capsaicin, dihydrocapsaicin, norcapsaicin, dihydrocapsaicin, homocapsaicin, homodihydrocapsaicin) are well known and used as nutritional additive agents in the every day nutritional practice from the last 9,500 years; however, we had have a very little scientifically based knowledge on their chemistry, physiology and pharmacology in animal observations, and in humans up to the mid-twentieth century. Our knowledge about their chemistry, physiology, pharmacology entered to be scientifically based evidence from the year 1980, dominantly in animal observations. The human observations with capsaicin (capsaicinoids), in terms of good clinical practice, have been started only in the last 10-year period (from 1997) in randomized, prospective, multiclinical studies. The name of "capsaicin" used only in the physiological and pharmacological research both in animal experiments and in human observation. The "capsaicin" (as a "chemically" used natural compound) modifies the so-called capsaicin-sensitive afferent nerves depending on their applied doses. AIMS: The specific action of capsaicin (capsaicinoids) on sensory afferent nerves modifying gastrointestinal (GI) function (under very specific conditions) offers a possibility for the production of an orally applicable drug or for other drug combinations, which can be used in the human medical therapy. The production of new drug is based on the critical interdisciplinary review of the results obtained with capsaicinoids.
MATERIALS AND METHODS: This paper gives an interdisciplinary and critical overview on the chemical, physiological, pharmacological and toxicological actions of the natural origin capsaicinoids (from the point of drug production) under conditions of acute, subacute and chronic administration in animal experiments and human observations, toxicology, pharmacokinetics). This interdisciplinary review covers the following main chapters: (1) physiological and pharmacological research tool by capsaicin in the animals and human beings, (2) capsaicin research in animals (including the acute, subacute toxicology and chronic toxicology metabolism, genotoxicology), (3) capsaicin observation with capsaicin in human beings.
CONCLUSION: (1) The capsaicin used in the physiological and pharmacological observations (in animals and human beings) chemically represents different chemical compounds, which can be obtained from the plants (paprika, chilli, etc.), (2) capsaicinoids are able to modify the capsaicin-sensitive afferent nerves, which have principle roles in the defence of different organs (including the gastrointestinal tract [against the different chemicals, heat, strech, chemical millieu-induced damage], (3) the application of capsaicin (capsaicinoids) can be repeated for the beneficial effects on the gastrointestinal tract as those in animal experiments. After this interdisciplinary and critical review, this paper demonstrates the well-planned research pathways of the discoveries of capsaicinoids from plant chemistry, via physiology, pharmacology and toxicology in animal experiments and human observations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557311     DOI: 10.1007/s10787-009-0002-3

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  153 in total

1.  Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa.

Authors:  P Holzer; M A Pabst; I T Lippe
Journal:  Gastroenterology       Date:  1989-06       Impact factor: 22.682

2.  Micronuclei and sister chromatid exchanges induced by capsaicin in human lymphocytes.

Authors:  S Marques; N G Oliveira; T Chaveca; J Rueff
Journal:  Mutat Res       Date:  2002-05-27       Impact factor: 2.433

3.  Influence of capsaicin-sensitive afferent fibers on acetic acid-induced chronic gastric ulcers in rats.

Authors:  M Tramontana; D Renzi; A Calabrò; C Panerai; S Milani; C Surrenti; S Evangelista
Journal:  Scand J Gastroenterol       Date:  1994-05       Impact factor: 2.423

4.  Cytotoxicity and genotoxicity of capsaicin in human neuroblastoma cells SHSY-5Y.

Authors:  F Richeux; M Cascante; R Ennamany; D Saboureau; E E Creppy
Journal:  Arch Toxicol       Date:  1999-09       Impact factor: 5.153

Review 5.  Forty years in capsaicin research for sensory pharmacology and physiology.

Authors:  János Szolcsányi
Journal:  Neuropeptides       Date:  2004-12       Impact factor: 3.286

6.  Increase in gastric secretion induced by 2-deoxy-D-glucose is impaired in capsaicin pretreated rats.

Authors:  S Evangelista; P Santicioli; C A Maggi; A Meli
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons.

Authors:  P Holzer; W Sametz
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

8.  Modulation by opioids and by afferent sensory neurones of prostanoid protection of the rat gastric mucosa.

Authors:  J V Esplugues; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

9.  Depletion of primary afferent substance P by capsaicin and dihydrocapsaicin without altered thermal sensitivity in rats.

Authors:  S H Buck; M S Miller; T F Burks
Journal:  Brain Res       Date:  1982-02-04       Impact factor: 3.252

10.  ATP breakdown and resynthesis in the development of gastrointestinal mucosal damage and its prevention in animals and human (an overview of 25 years ulcer research studies).

Authors:  G Mózsik; A Király; G Sütö; A Vincze
Journal:  Acta Physiol Hung       Date:  1992
View more
  5 in total

1.  Exposure to non-steroid anti-inflammatory drugs (NSAIDs) and suppressing hydrogen sulfide synthesis leads to altered structure and impaired function of the oesophagus and oesophagogastric junction.

Authors:  Oksana Zayachkivska; Nazar Bula; Dzvinka Khyrivska; Elena Gavrilyuk; John L Wallace
Journal:  Inflammopharmacology       Date:  2015-02-25       Impact factor: 4.473

Review 2.  Bioavailability of capsaicin and its implications for drug delivery.

Authors:  William D Rollyson; Cody A Stover; Kathleen C Brown; Haley E Perry; Cathryn D Stevenson; Christopher A McNees; John G Ball; Monica A Valentovic; Piyali Dasgupta
Journal:  J Control Release       Date:  2014-10-12       Impact factor: 9.776

Review 3.  Histamine: an undercover agent in multiple rare diseases?

Authors:  Almudena Pino-Ángeles; Armando Reyes-Palomares; Esther Melgarejo; Francisca Sánchez-Jiménez
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

Review 4.  Biological Properties, Bioactive Constituents, and Pharmacokinetics of Some Capsicum spp. and Capsaicinoids.

Authors:  Gaber El-Saber Batiha; Ali Alqahtani; Oluwafemi Adeleke Ojo; Hazem M Shaheen; Lamiaa Wasef; Mahmoud Elzeiny; Mahmoud Ismail; Mahmoud Shalaby; Toshihiro Murata; Adrian Zaragoza-Bastida; Nallely Rivero-Perez; Amany Magdy Beshbishy; Keneth Iceland Kasozi; Philippe Jeandet; Helal F Hetta
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

Review 5.  Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other Diseases.

Authors:  Shaherin Basith; Minghua Cui; Sunhye Hong; Sun Choi
Journal:  Molecules       Date:  2016-07-23       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.